John D. Hooper1 / * Institute of Health / Queensland University of Technology / /
IndustryTerm
activation site / cleavage site / fusion product / receptor activation site / predominant site / /
MedicalCondition
primary prostate cancer / Causes PAR2 dependent inflammation / benign prostate disease / hormone resistant disease / advanced prostate cancer / cancer / BPH / prostate adenocarcinoma / late stage cancer / prostate cancer lymph node metastasis / prostatic intraepithelial neoplasia / metastasis / lower grade tumours / higher Gleason grade cancers / tumour / prostate cancer brain metastasis / bone metastases / bone metastasis / diseases / early and advanced tumours / prostate cancer bone metastasis / ERG fusion prostate cancers / early stage disease / benign prostatic hyperplasia / prostate cancer / inflammation / androgen independent stage disease / prostate carcinoma / /
Organization
Queensland University of Technology / G7 / Department of Anatomical / A. Clements1 and John D. Hooper1 / * Institute of Health and Biomedical Innovation / ND ND / /
Person
Molino / Walter de Gruyter / Turk / Kelvin Grove / /
This is the author’s version of a work that was submitted/accepted for publication in the following source: Ramsay, Andrew J., Reid, Janet C., Adams, Mark N., Samaratunga, Hemamali, Dong, Ying, Clements, Judith A., & H